lactic acid and resolvin d1

lactic acid has been researched along with resolvin d1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chatterjee, A; Chen, M; Conte, MS; Desai, TA; Lance, KD; Mottola, G; Siguenza, IO; Wu, B1
Chatterjee, A; Conte, MS; Desai, TA; Lance, KD; Lee, PP; Mottola, G; Nuhn, H; Sansbury, BE; Spite, M; Wu, B1
Botchwey, EA; Olingy, CE; San Emeterio, CL; Sok, MCP; Tria, MC1

Other Studies

3 other study(ies) available for lactic acid and resolvin d1

ArticleYear
Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Journal of vascular surgery, 2017, Volume: 65, Issue:1

    Topics: Angioplasty, Balloon; Animals; Aorta; Cardiovascular Agents; Carotid Artery Diseases; Cell Movement; Cell Proliferation; Cells, Cultured; Cytoskeleton; Disease Models, Animal; Docosahexaenoic Acids; Drug Carriers; Drug Compounding; Hyperplasia; Inflammation Mediators; Ki-67 Antigen; Lactic Acid; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Oxidative Stress; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Time Factors; Transcription Factor RelA

2017
Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device.
    Journal of biomedical materials research. Part A, 2017, Volume: 105, Issue:1

    Topics: Absorbable Implants; Animals; Docosahexaenoic Acids; Drug Implants; Humans; Lactic Acid; Male; Membranes, Artificial; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rats; Rats, Sprague-Dawley

2017
Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling.
    Acta biomaterialia, 2017, 04-15, Volume: 53

    Topics: Animals; Aspirin; Biocompatible Materials; Cytokines; Docosahexaenoic Acids; Drug Delivery Systems; Immune System; Inflammation; Lactic Acid; Male; Materials Testing; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RAW 264.7 Cells; Regeneration; Tissue Engineering; Vascular Remodeling

2017